Abstract

(Abstracted from N Engl J Med 2020;383:1340–1348) Because of the well-established association between oncogenic types of human papillomavirus (HPV) and cervical cancer, as of December 2019 a total of 124 countries and territories had implemented HPV vaccination programs. Studies have demonstrated that HPV vaccination protects against HPV infection, genital warts, and high-grade precancerous cervical lesions.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.